Study Shows How Stem Cells Decide Liver, Pancreas Formation

A gradient of prostaglandin E2 in the region of zebrafish embryos where stem cells differentiate into the internal organs has been discovered by Stem cell scientists.

A gradient of prostaglandin E2 in the region of zebrafish embryos where stem cells differentiate into the internal organs has been discovered by Stem cell scientists Wolfram Goessling and Trista Northat the Harvard Stem Cell Institute (HSCI).

The finding could potentially make liver and pancreas cells easier to generate both in the lab and for future cell therapies.

About Stem Cells
Encyclopedia section of medindia gives general info about Stem Cells

"Cells that see more prostaglandin become liver and the cells that see less prostaglandin become pancreas," said Goessling, assistant professor of medicine.

This is the first time that prostaglandin is being reported as a factor that can lead this 'fate switch' and essentially instruct what kind of identity a cell is going to be, the researchers added.

Other experiments showed that prostaglandin E2 could also enhance liver growth and regeneration of liver cells.

Quiz on Stem Cells
Scientists believe (and are working hard) to use stem cells in the future to treat a wide range of diseases and injuries. But what exactly is a stem cell? How can it be used in curing disorders? See if you get your answers from this quiz.

"Prostaglandin might be a master regulator of cell growth in different organs," Goessling said.

It's used in cord blood, as we have shown, it works in the liver, and who knows what other organs might be affected by it, revealed the findings published in the journal Developmental Cell.

Histones may Hold the Key to the Generation of Totipotent Stem Cells: Study
A pair of histone proteins that enhance the generation of induced pluripotent stem cells may be the key to generating induced totipotent stem cells, say researchers.

Source-IANS

Lung Disease in Preterm Infants can be Managed With Stem Cells
Stem cells have found to be a safe and feasible treatment for preterm infants with bronchopulmonary dysplasia (BPD), in a new study scheduled for publication in The Journal of Pediatrics.